Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-55.28M.
ENTERPRISE VALUE (EV)
$-55.28M
Filana Therapeutics, Inc.
Market Cap
$40.22M
Enterprise Value (EV)
$-55.28M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | $40.22M | $-55.28M |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.09M | $38.79M |
| Nephros, Inc. (NEPH)vs › | $39.84M | $36.02M |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.88M | $76.58M |
| Precipio, Inc. (PRPO)vs › | $41.92M | $42.18M |
| Incannex Healthcare Limited (IXHL)vs › | $37.74M | N/A |
| Edesa Biotech, Inc. (EDSA)vs › | $37.67M | $27.33M |
| SANUWAVE Health Inc. (SNWV)vs › | $43.17M | $54.50M |
| Elicio Therapeutics, Inc. (ELTX)vs › | $37.06M | $27.73M |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.83M | $20.53M |
Market Cap
$40.22M
Total Debt
$0.00
Cash
$95.50M
Enterprise Value
$-55.28M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
